1. Hungary Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Nutex Investments Plc Series E

Nutex Investments Plc Series E

BBUD:NUTEX
12.25
HUF
-0.20
(-1.61%)
2.84BMarket Cap
Nutex Investments Plc Series E
BUD:NUTEX
(Budapest Stock Exchange)

Recent

price

12.25

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
HUF
1,591.36
980.83
1,398.59
642.24
389.53
2.37
43.14
2.18
0.31
0.03
0.01
- -
- -
- -
- -
- -
- -
Revenue per Share
111.96
47.27
-60.83
8.88
37.24
46.05
-55.97
-82.05
-28.38
-0.3
0.36
0.1
0.9
1.13
3.25
3.8
- -
Basic EPS, GAAP
-81.82
-18.68
7.25
-1.13
-10.31
-16.37
-15.7
-2.22
-1.59
-1.94
1.05
-3.55
-7.96
-3.55
-0.94
1.97
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
156,898.24
807.76
704.23
703.95
500.45
479.78
431.72
171.08
64.89
47.25
39.07
34.87
35.77
36.83
38.09
42.4
38.09
Book Value per Share
81,130.85
475.14
473.28
480.56
362.14
476.91
429.87
170.7
64.89
47.25
39.07
34.87
35.77
36.83
38.09
42.4
38.09
Tangible Book Value per Share
1
2
2
2
3
3
3
4
13
26
72
129
148
151
130
130
140
Basic Weighted Avg Shares
1,298
1,763
2,521
1,135
1,018
7
126
9
4
1
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
1.87
2.15
-0.78
-0.91
-4.44
-202.08
-8.04
-43.22
-222.57
-1,286.27
-4,124
-2,868
-3,548
-4,643.56
-21,482
-24,097.78
- -
Operating Margin (%)
53
46
42
28
26
11
3
3
2
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
91
85
-110
16
97
129
-164
-330
-376
-8
26
13
134
171
423
494
- -
Net Income, GAAP
3.78
- -
- -
20.85
- -
- -
- -
- -
- -
- -
4.5
4.51
3.74
3.82
9.17
9
- -
Effective Tax Rate (%)
7.04
4.82
-4.35
1.38
9.56
1,941.63
-129.72
-3,771.46
-9,096.42
-1,068.4
5,797.11
2,819.33
29,672.44
38,027.56
94,091.56
109,815.78
- -
Profit Margin (%)
61
192
31
80
248
-34
-47
72
306
1,002
2,785
4,347
4,481
5,471
4,956
5,519
4,956
Working Capital
98
96
92
93
215
225
252
262
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
1,527
1,738
1,339
1,339
1,541
1,345
1,199
998
1,125
1,821
3,604
5,167
5,300
5,472
4,956
5,520
4,956
Total Equity
1.15
- -
- -
-5.13
- -
-0.85
- -
- -
- -
- -
-0.65
-0.28
-0.29
-0.37
-1.68
-1.87
- -
Return on Invested Capital (%)
4.02
- -
- -
3.7
- -
7.27
- -
- -
- -
- -
1.06
0.44
2.62
7.61
8.12
9.43
- -
Return on Capital (%)
7.03
6.3
-8.21
1.26
7.41
9.46
-12.88
-30.19
-36.58
-0.57
0.98
0.29
2.55
3.18
8.13
9.44
- -
Return on Common Equity (%)

Capital Structure

HUF

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
16
- -
- -
Shares Outstanding
148
148
130
Market Capitalization
2,103
2,118
2,836

Working Capital

HUF

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
Total Current Assets
5,480
5,743
4,998
Cash, Cash Equivalents & STI
4,136
5,066
4,773
Accounts Receivable, Net
- -
1
1
Inventories
- -
- -
- -
Total Current Liabilities
9
3
42
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

HUF

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
19.6%
10.22%
11.37%
Free Cash Flow
- -
-198.04%
-309.34%
Net Income, GAAP
45.9%
218.68%
16.71%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HUF

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Semi-annual Earnings Per Share

HUF

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1.13
2024
- -
- -
3.25
2025
- -
- -
3.8

Semi-annual Dividends Per Share

HUF

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -
Similar Companies
Eli Lilly and Company (NYSE:LLY)
Novo Nordisk A/S (NYSE:NVO)
Johnson & Johnson (NYSE:JNJ)
Pfizer, Inc. (NYSE:PFE)
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY)
Divi's Laboratories Limited (NSE:DIVISLAB)
Business
Nutex Investments Plc is a Hungary-based financial holding and investment management company engaged in strategic asset management, private equity investments, venture capital financing, and corporate advisory services. Founded in 1994 and headquartered in Budapest, Hungary, the company focuses on capital market operations and equity participations across Central and Eastern Europe. Nutex Investments provides a comprehensive suite of financial and investment solutions structured across dedicated investment verticals, including: direct equity and venture capital financing for high-growth enterprises; portfolio asset management and capital allocation; corporate finance, reorganization, and turnaround advisory; strategic management consulting and board-level governance support; private debt structuring and placement facilitation; and incubation services for emerging business models. The firm targets small-to-mid cap enterprises and innovative companies operating in financial technology, renewable energy, healthcare, real estate development, and industrial technologies. In recent operational developments, Nutex Investments has executed strategic portfolio realignment initiatives aimed at expanding its exposure to sustainable technology and European digital innovation sectors. The company has conducted multiple capital restructuring measures, including private placement share issuances and convertible capital instruments to enhance treasury liquidity, while forging strategic co-investment alliances with regional investment syndicates and divesting non-core legacy assets to strengthen its net asset value and streamline holding operations.